| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mental Retardation, X-Linked | 7 | 2024 | 94 | 3.100 |
Why?
|
| Neurodevelopmental Disorders | 16 | 2024 | 413 | 2.760 |
Why?
|
| Sinus Thrombosis, Intracranial | 2 | 2022 | 42 | 1.610 |
Why?
|
| Charcot-Marie-Tooth Disease | 6 | 2023 | 192 | 1.470 |
Why?
|
| Microcephaly | 12 | 2024 | 325 | 1.410 |
Why?
|
| DNA Copy Number Variations | 12 | 2024 | 1516 | 1.350 |
Why?
|
| Intellectual Disability | 13 | 2024 | 1032 | 1.290 |
Why?
|
| Pedigree | 30 | 2023 | 1890 | 1.170 |
Why?
|
| Phenotype | 29 | 2023 | 6295 | 1.060 |
Why?
|
| Arthrogryposis | 3 | 2022 | 34 | 1.040 |
Why?
|
| Nervous System Malformations | 6 | 2024 | 133 | 1.030 |
Why?
|
| Exome | 16 | 2020 | 1239 | 0.900 |
Why?
|
| Homozygote | 12 | 2024 | 717 | 0.890 |
Why?
|
| Rett Syndrome | 2 | 2023 | 262 | 0.890 |
Why?
|
| Mutation | 29 | 2023 | 15179 | 0.880 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2022 | 7 | 0.850 |
Why?
|
| Genomics | 6 | 2022 | 2738 | 0.840 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 334 | 0.730 |
Why?
|
| Mutation, Missense | 7 | 2021 | 1152 | 0.710 |
Why?
|
| De Lange Syndrome | 4 | 2018 | 43 | 0.680 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 186 | 0.670 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 5 | 2023 | 291 | 0.670 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 148 | 0.660 |
Why?
|
| DNA Replication | 2 | 2013 | 744 | 0.650 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 589 | 0.640 |
Why?
|
| Genetic Association Studies | 6 | 2021 | 1084 | 0.630 |
Why?
|
| Parents | 2 | 2024 | 998 | 0.620 |
Why?
|
| Scoliosis | 4 | 2020 | 139 | 0.600 |
Why?
|
| Child, Preschool | 31 | 2024 | 16273 | 0.600 |
Why?
|
| Gene Rearrangement | 4 | 2021 | 783 | 0.600 |
Why?
|
| Membrane Proteins | 7 | 2022 | 2819 | 0.580 |
Why?
|
| Child | 34 | 2024 | 29154 | 0.570 |
Why?
|
| Genetic Markers | 1 | 2019 | 974 | 0.560 |
Why?
|
| Dystonia | 3 | 2023 | 163 | 0.560 |
Why?
|
| Caregivers | 1 | 2022 | 677 | 0.550 |
Why?
|
| Movement Disorders | 3 | 2024 | 232 | 0.550 |
Why?
|
| Myelin Proteins | 2 | 2015 | 90 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2021 | 5539 | 0.540 |
Why?
|
| Stroke | 2 | 2022 | 1144 | 0.540 |
Why?
|
| Polyneuropathies | 1 | 2015 | 28 | 0.540 |
Why?
|
| Loss of Heterozygosity | 3 | 2021 | 602 | 0.520 |
Why?
|
| Infant | 21 | 2024 | 13310 | 0.510 |
Why?
|
| Epilepsy | 7 | 2022 | 883 | 0.510 |
Why?
|
| Nerve Tissue Proteins | 5 | 2022 | 1491 | 0.500 |
Why?
|
| Vesicular Transport Proteins | 3 | 2021 | 135 | 0.500 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 3343 | 0.490 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 3 | 2023 | 24 | 0.480 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 82 | 0.480 |
Why?
|
| Humans | 96 | 2024 | 261506 | 0.480 |
Why?
|
| DNA Breaks | 1 | 2013 | 39 | 0.470 |
Why?
|
| Abnormalities, Multiple | 4 | 2020 | 998 | 0.460 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 336 | 0.450 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 369 | 0.450 |
Why?
|
| Trichothiodystrophy Syndromes | 1 | 2012 | 3 | 0.450 |
Why?
|
| Genetic Variation | 7 | 2021 | 2086 | 0.440 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2023 | 1265 | 0.440 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2012 | 69 | 0.440 |
Why?
|
| Turkey | 5 | 2021 | 57 | 0.410 |
Why?
|
| Lissencephaly | 2 | 2022 | 10 | 0.400 |
Why?
|
| Constipation | 2 | 2023 | 177 | 0.400 |
Why?
|
| Epilepsy, Generalized | 2 | 2022 | 71 | 0.390 |
Why?
|
| Male | 55 | 2024 | 123000 | 0.380 |
Why?
|
| Proteins | 4 | 2016 | 1963 | 0.370 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 309 | 0.370 |
Why?
|
| Cerebellar Diseases | 3 | 2020 | 89 | 0.370 |
Why?
|
| Neuromuscular Diseases | 2 | 2020 | 63 | 0.370 |
Why?
|
| Growth Disorders | 3 | 2020 | 218 | 0.360 |
Why?
|
| Adolescent | 25 | 2024 | 31252 | 0.360 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8223 | 0.360 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2015 | 393 | 0.350 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 613 | 0.340 |
Why?
|
| Gene Duplication | 4 | 2023 | 421 | 0.340 |
Why?
|
| Brain Diseases | 2 | 2023 | 403 | 0.340 |
Why?
|
| Quality of Life | 1 | 2022 | 4532 | 0.320 |
Why?
|
| Female | 49 | 2024 | 141928 | 0.310 |
Why?
|
| Alleles | 11 | 2023 | 2437 | 0.300 |
Why?
|
| Atrophy | 5 | 2020 | 261 | 0.300 |
Why?
|
| Comparative Genomic Hybridization | 5 | 2021 | 691 | 0.300 |
Why?
|
| Cell Cycle Proteins | 6 | 2019 | 2045 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2008 | 272 | 0.290 |
Why?
|
| Eczema | 2 | 2020 | 37 | 0.290 |
Why?
|
| Inheritance Patterns | 2 | 2019 | 139 | 0.280 |
Why?
|
| Muscular Dystrophies | 2 | 2023 | 51 | 0.270 |
Why?
|
| Cohort Studies | 9 | 2021 | 9244 | 0.270 |
Why?
|
| Calcium Channels | 2 | 2019 | 197 | 0.270 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 674 | 0.270 |
Why?
|
| DNA Repair | 1 | 2013 | 1872 | 0.260 |
Why?
|
| Bardet-Biedl Syndrome | 2 | 2016 | 38 | 0.260 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2023 | 534 | 0.250 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 442 | 0.240 |
Why?
|
| Adult | 21 | 2024 | 77950 | 0.240 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2022 | 81 | 0.240 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2018 | 362 | 0.240 |
Why?
|
| Zebrafish | 7 | 2024 | 463 | 0.230 |
Why?
|
| Base Sequence | 7 | 2017 | 4917 | 0.230 |
Why?
|
| Cerebellum | 4 | 2021 | 449 | 0.230 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 94 | 0.230 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2023 | 37 | 0.230 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 500 | 0.230 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2022 | 14 | 0.220 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.220 |
Why?
|
| Eye Abnormalities | 2 | 2021 | 118 | 0.220 |
Why?
|
| Contracture | 1 | 2022 | 32 | 0.220 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2022 | 10 | 0.210 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.210 |
Why?
|
| Urogenital Abnormalities | 2 | 2022 | 174 | 0.210 |
Why?
|
| Repressor Proteins | 3 | 2020 | 1664 | 0.210 |
Why?
|
| Dystonic Disorders | 1 | 2023 | 81 | 0.210 |
Why?
|
| Apyrase | 1 | 2022 | 44 | 0.210 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 30 | 0.210 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 78 | 0.210 |
Why?
|
| Chromosomes, Human, X | 2 | 2021 | 192 | 0.210 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 5687 | 0.210 |
Why?
|
| Cranial Sinuses | 1 | 2022 | 24 | 0.210 |
Why?
|
| Muscular Diseases | 1 | 2023 | 161 | 0.210 |
Why?
|
| Neural Conduction | 3 | 2020 | 112 | 0.210 |
Why?
|
| Decompressive Craniectomy | 1 | 2022 | 13 | 0.210 |
Why?
|
| Heterozygote | 6 | 2018 | 1020 | 0.210 |
Why?
|
| Brain | 6 | 2022 | 4113 | 0.210 |
Why?
|
| Animals | 26 | 2024 | 59536 | 0.210 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 203 | 0.200 |
Why?
|
| MELAS Syndrome | 1 | 2022 | 37 | 0.200 |
Why?
|
| Facies | 4 | 2020 | 149 | 0.200 |
Why?
|
| Young Adult | 11 | 2024 | 21445 | 0.200 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2021 | 4 | 0.200 |
Why?
|
| Brain Edema | 1 | 2022 | 86 | 0.200 |
Why?
|
| T-Box Domain Proteins | 2 | 2020 | 156 | 0.200 |
Why?
|
| Urinary Tract | 1 | 2022 | 82 | 0.200 |
Why?
|
| Fibroblasts | 4 | 2023 | 1682 | 0.200 |
Why?
|
| Syndrome | 5 | 2023 | 1351 | 0.190 |
Why?
|
| Sequence Deletion | 4 | 2021 | 875 | 0.190 |
Why?
|
| Alu Elements | 1 | 2021 | 88 | 0.190 |
Why?
|
| Mediator Complex | 1 | 2021 | 69 | 0.190 |
Why?
|
| Chromosome Duplication | 1 | 2021 | 157 | 0.190 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 132 | 0.190 |
Why?
|
| Family | 4 | 2020 | 736 | 0.190 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 63 | 0.190 |
Why?
|
| Fibrillar Collagens | 1 | 2020 | 19 | 0.190 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 365 | 0.190 |
Why?
|
| Founder Effect | 1 | 2020 | 42 | 0.190 |
Why?
|
| Symporters | 1 | 2021 | 98 | 0.190 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 1005 | 0.190 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 318 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 2291 | 0.180 |
Why?
|
| Chromosome Breakpoints | 3 | 2019 | 104 | 0.180 |
Why?
|
| Netrins | 1 | 2019 | 7 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 577 | 0.180 |
Why?
|
| Hip Dislocation | 1 | 2020 | 27 | 0.180 |
Why?
|
| Muscle Hypotonia | 2 | 2022 | 180 | 0.180 |
Why?
|
| Encephalitis | 1 | 2021 | 143 | 0.180 |
Why?
|
| Ribosomes | 1 | 2020 | 147 | 0.180 |
Why?
|
| Genes, Dominant | 1 | 2020 | 331 | 0.180 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 63 | 0.180 |
Why?
|
| White Matter | 1 | 2022 | 195 | 0.180 |
Why?
|
| Connectin | 1 | 2019 | 30 | 0.180 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 137 | 0.170 |
Why?
|
| Genome, Human | 3 | 2020 | 1869 | 0.170 |
Why?
|
| Mice | 17 | 2023 | 34495 | 0.170 |
Why?
|
| Autistic Disorder | 1 | 2022 | 319 | 0.170 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 110 | 0.170 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 140 | 0.170 |
Why?
|
| Alopecia | 2 | 2023 | 126 | 0.170 |
Why?
|
| Psychometrics | 1 | 2024 | 937 | 0.170 |
Why?
|
| Osteomyelitis | 1 | 2022 | 236 | 0.170 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 223 | 0.170 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 321 | 0.170 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 72 | 0.170 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 22 | 0.170 |
Why?
|
| Neoplasm Proteins | 3 | 2023 | 3230 | 0.170 |
Why?
|
| Genotype | 4 | 2018 | 4109 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 3 | 2008 | 3976 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2011 | 5437 | 0.160 |
Why?
|
| Frameshift Mutation | 2 | 2023 | 220 | 0.160 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 239 | 0.160 |
Why?
|
| Fibromatosis, Gingival | 1 | 2017 | 4 | 0.160 |
Why?
|
| Naegleria fowleri | 1 | 2017 | 4 | 0.150 |
Why?
|
| Central Nervous System Protozoal Infections | 1 | 2017 | 4 | 0.150 |
Why?
|
| Spasms, Infantile | 1 | 2019 | 165 | 0.150 |
Why?
|
| Molecular Sequence Data | 6 | 2016 | 6089 | 0.150 |
Why?
|
| Mosaicism | 1 | 2019 | 272 | 0.150 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 128 | 0.150 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 244 | 0.150 |
Why?
|
| Consanguinity | 3 | 2022 | 114 | 0.140 |
Why?
|
| Software | 1 | 2024 | 1321 | 0.140 |
Why?
|
| Exons | 2 | 2017 | 1328 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 6009 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2022 | 787 | 0.140 |
Why?
|
| Hypogonadism | 2 | 2019 | 257 | 0.140 |
Why?
|
| Genetic Load | 1 | 2015 | 5 | 0.140 |
Why?
|
| Myelin P0 Protein | 1 | 2015 | 27 | 0.140 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2015 | 11 | 0.140 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2019 | 362 | 0.140 |
Why?
|
| Gene Dosage | 1 | 2019 | 829 | 0.130 |
Why?
|
| Gestational Age | 1 | 2019 | 1069 | 0.130 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2015 | 7 | 0.130 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 862 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 100 | 0.130 |
Why?
|
| Sequence Alignment | 2 | 2020 | 844 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 849 | 0.130 |
Why?
|
| Motor Neurons | 1 | 2015 | 138 | 0.130 |
Why?
|
| Hypopituitarism | 1 | 2015 | 33 | 0.130 |
Why?
|
| Anxiety | 1 | 2022 | 1179 | 0.130 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2014 | 16 | 0.130 |
Why?
|
| Anodontia | 1 | 2014 | 22 | 0.120 |
Why?
|
| Pituitary Gland | 1 | 2015 | 150 | 0.120 |
Why?
|
| Neurons | 2 | 2022 | 2287 | 0.120 |
Why?
|
| Anophthalmos | 1 | 2014 | 23 | 0.120 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 164 | 0.120 |
Why?
|
| Phosphotransferases | 1 | 2014 | 84 | 0.120 |
Why?
|
| Refsum Disease | 1 | 2013 | 4 | 0.120 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2013 | 37 | 0.120 |
Why?
|
| RNA, Transfer | 1 | 2014 | 77 | 0.120 |
Why?
|
| Kartagener Syndrome | 1 | 2013 | 12 | 0.120 |
Why?
|
| Armadillo Domain Proteins | 1 | 2013 | 21 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 4233 | 0.120 |
Why?
|
| Dyneins | 1 | 2013 | 31 | 0.120 |
Why?
|
| Prevalence | 1 | 2021 | 3260 | 0.120 |
Why?
|
| Autophagy | 1 | 2020 | 927 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 129 | 0.110 |
Why?
|
| Age of Onset | 1 | 2015 | 827 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 1439 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 3 | 2020 | 2483 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2022 | 37905 | 0.110 |
Why?
|
| Disease | 1 | 2014 | 165 | 0.110 |
Why?
|
| Genes, Recessive | 3 | 2021 | 200 | 0.110 |
Why?
|
| Cilia | 1 | 2013 | 92 | 0.110 |
Why?
|
| Body Patterning | 1 | 2013 | 212 | 0.110 |
Why?
|
| Eye Proteins | 1 | 2014 | 269 | 0.110 |
Why?
|
| Curcumin | 1 | 2013 | 117 | 0.110 |
Why?
|
| Respiratory System | 1 | 2013 | 125 | 0.110 |
Why?
|
| Receptors, Notch | 1 | 2015 | 383 | 0.110 |
Why?
|
| Gene Frequency | 3 | 2020 | 1163 | 0.100 |
Why?
|
| Depression | 1 | 2022 | 1715 | 0.100 |
Why?
|
| Gene Order | 1 | 2012 | 111 | 0.100 |
Why?
|
| IgA Deficiency | 1 | 2011 | 6 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 204 | 0.100 |
Why?
|
| Protein Conformation | 2 | 2014 | 1258 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2014 | 842 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 4549 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 677 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 488 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 622 | 0.100 |
Why?
|
| Mammals | 2 | 2023 | 361 | 0.100 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2010 | 4 | 0.100 |
Why?
|
| Tubulin | 2 | 2022 | 169 | 0.100 |
Why?
|
| Chromosome Mapping | 2 | 2019 | 1471 | 0.100 |
Why?
|
| X Chromosome Inactivation | 2 | 2021 | 73 | 0.100 |
Why?
|
| Rare Diseases | 2 | 2024 | 351 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 1408 | 0.090 |
Why?
|
| DNA Mutational Analysis | 5 | 2014 | 2283 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 521 | 0.090 |
Why?
|
| Axons | 2 | 2022 | 403 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2992 | 0.090 |
Why?
|
| DNA Helicases | 2 | 2023 | 434 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 829 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2015 | 11965 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2022 | 5710 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 14889 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2008 | 1064 | 0.070 |
Why?
|
| Receptor, EphA2 | 1 | 2008 | 132 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 7702 | 0.070 |
Why?
|
| Middle Aged | 7 | 2024 | 86204 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2012 | 1442 | 0.070 |
Why?
|
| Drosophila | 2 | 2022 | 839 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 575 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 4053 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2014 | 1589 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 1859 | 0.070 |
Why?
|
| Kidney | 3 | 2022 | 2146 | 0.070 |
Why?
|
| Chromosome Segregation | 2 | 2017 | 82 | 0.070 |
Why?
|
| Spine | 2 | 2019 | 293 | 0.070 |
Why?
|
| Gastrulation | 2 | 2016 | 24 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2010 | 1732 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2022 | 5270 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2023 | 1489 | 0.060 |
Why?
|
| Cell Line | 2 | 2023 | 5114 | 0.060 |
Why?
|
| Seizures | 2 | 2021 | 989 | 0.060 |
Why?
|
| Databases, Genetic | 2 | 2019 | 745 | 0.060 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 11 | 0.060 |
Why?
|
| Mevalonic Acid | 1 | 2023 | 34 | 0.060 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2023 | 44 | 0.060 |
Why?
|
| Glycosylation | 1 | 2023 | 213 | 0.060 |
Why?
|
| Tight Junctions | 1 | 2023 | 56 | 0.060 |
Why?
|
| Codon, Terminator | 1 | 2023 | 42 | 0.060 |
Why?
|
| Iran | 1 | 2023 | 68 | 0.060 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 16 | 0.060 |
Why?
|
| Tremor | 1 | 2024 | 128 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 492 | 0.060 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 15 | 0.060 |
Why?
|
| Reverse Genetics | 1 | 2022 | 18 | 0.050 |
Why?
|
| Cell Movement | 2 | 2021 | 2466 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 24 | 0.050 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 2265 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 85 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2024 | 299 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2023 | 171 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2007 | 2074 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 91 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 1143 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 121 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 264 | 0.050 |
Why?
|
| Egypt | 1 | 2021 | 42 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 95 | 0.050 |
Why?
|
| Nitrogen | 1 | 2022 | 162 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 161 | 0.050 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 984 | 0.050 |
Why?
|
| Calpain | 1 | 2021 | 64 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 255 | 0.050 |
Why?
|
| Glycogen | 1 | 2021 | 80 | 0.050 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 6 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2007 | 1555 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2008 | 6150 | 0.050 |
Why?
|
| Peru | 1 | 2020 | 52 | 0.050 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.050 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 21 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 344 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 268 | 0.050 |
Why?
|
| Glutamine | 1 | 2022 | 299 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2019 | 1113 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2020 | 43 | 0.050 |
Why?
|
| Electromyography | 1 | 2020 | 226 | 0.050 |
Why?
|
| Myositis | 1 | 2020 | 79 | 0.040 |
Why?
|
| Bone Development | 1 | 2020 | 83 | 0.040 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2019 | 10 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2021 | 278 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2020 | 111 | 0.040 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 74 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 392 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 370 | 0.040 |
Why?
|
| Deafness | 1 | 2020 | 82 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 344 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 2019 | 72 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 576 | 0.040 |
Why?
|
| Cataract | 1 | 2021 | 218 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2019 | 266 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 7222 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 370 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 270 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 208 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2008 | 6100 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 144 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 332 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 112 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 119 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 233 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 324 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2021 | 641 | 0.040 |
Why?
|
| Siblings | 1 | 2019 | 285 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 323 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 549 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 3168 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 590 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 854 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 561 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 445 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 769 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 554 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 1048 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 621 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 6942 | 0.030 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 35 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 1546 | 0.030 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 1245 | 0.030 |
Why?
|
| Myelin P2 Protein | 1 | 2015 | 11 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2015 | 29 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2022 | 858 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 621 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2015 | 67 | 0.030 |
Why?
|
| Gene Expression | 2 | 2014 | 3570 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 163 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 126 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 38 | 0.030 |
Why?
|
| Exonucleases | 1 | 2015 | 51 | 0.030 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 61 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 281 | 0.030 |
Why?
|
| Survival Rate | 1 | 2008 | 12221 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2014 | 23 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 78 | 0.030 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2014 | 23 | 0.030 |
Why?
|
| Coloboma | 1 | 2014 | 43 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 1960 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 2139 | 0.030 |
Why?
|
| Microphthalmos | 1 | 2014 | 57 | 0.030 |
Why?
|
| Cerebrum | 1 | 2014 | 44 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 115 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1270 | 0.030 |
Why?
|
| Axoneme | 1 | 2013 | 8 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 6086 | 0.030 |
Why?
|
| X Chromosome | 1 | 2014 | 339 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2015 | 128 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 4314 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2014 | 107 | 0.030 |
Why?
|
| Prognosis | 2 | 2008 | 21713 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2013 | 112 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 197 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2013 | 115 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 4078 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 161 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 3443 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2017 | 898 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 634 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8873 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2014 | 481 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 461 | 0.030 |
Why?
|
| Retina | 1 | 2015 | 532 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 487 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 343 | 0.020 |
Why?
|
| Inflammation | 1 | 2021 | 2522 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 1487 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 1904 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 78 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2018 | 2022 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 5159 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 2488 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 829 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 10331 | 0.020 |
Why?
|
| Apoptosis | 1 | 2022 | 7591 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1498 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 4821 | 0.020 |
Why?
|
| Aged | 2 | 2008 | 70117 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 995 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2007 | 1090 | 0.010 |
Why?
|
| United States | 1 | 2019 | 15433 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 1823 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 5112 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 9180 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 15862 | 0.010 |
Why?
|